Risk prediction models for colorectal cancer in people with symptoms: a systematic review

被引:44
|
作者
Williams, Tom G. S. [2 ]
Cubiella, Joaquin [3 ]
Griffin, Simon J. [1 ]
Walter, Fiona M. [1 ]
Usher-Smith, Juliet A. [1 ]
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB1 8RN, England
[2] Univ Cambridge, Sch Clin Med, Cambridge, England
[3] Complexo Hosp Univ Ourense, Inst Invest Biomed Ourense Vigo Pontevedra, Dept Gastroenterol, Orense, Spain
来源
BMC GASTROENTEROLOGY | 2016年 / 16卷
关键词
Colorectal cancer; Risk; Model; Symptoms; Prediction; PATIENT CONSULTATION QUESTIONNAIRE; PRIMARY-CARE; GENERAL-PRACTICE; SCORING SYSTEM; IDENTIFYING PATIENTS; CLINICAL-FEATURES; MEDICAL HISTORY; VALIDATION; DIAGNOSIS; POPULATION;
D O I
10.1186/s12876-016-0475-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Colorectal cancer (CRC) is the fourth leading cause of cancer-related death in Europe and the United States. Detecting the disease at an early stage improves outcomes. Risk prediction models which combine multiple risk factors and symptoms have the potential to improve timely diagnosis. The aim of this review is to systematically identify and compare the performance of models that predict the risk of primary CRC among symptomatic individuals. Methods: We searched Medline and EMBASE to identify primary research studies reporting, validating or assessing the impact of models. For inclusion, models needed to assess a combination of risk factors that included symptoms, present data on model performance, and be applicable to the general population. Screening of studies for inclusion and data extraction were completed independently by at least two researchers. Results: Twelve thousand eight hundred eight papers were identified from the literature search and three through citation searching. 18 papers describing 15 risk models were included. Nine were developed in primary care populations and six in secondary care. Four had good discrimination (AUROC > 0.8) in external validation studies, and sensitivity and specificity ranged from 0.25 and 0.99 to 0.99 and 0.46 depending on the cut-off chosen. Conclusions: Models with good discrimination have been developed in both primary and secondary care populations. Most contain variables that are easily obtainable in a single consultation, but further research is needed to assess clinical utility before they are incorporated into practice.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] A systematic review and quality assessment of individualised breast cancer risk prediction models
    Javier Louro
    Margarita Posso
    Michele Hilton Boon
    Marta Román
    Laia Domingo
    Xavier Castells
    María Sala
    [J]. British Journal of Cancer, 2019, 121 : 76 - 85
  • [32] Risk prediction models for symptomatic patients with bladder and kidney cancer: a systematic review
    Harrison, Hannah
    Usher-Smith, Juliet A.
    Li, Lanxin
    Roberts, Lydia
    Lin, Zhiyuan
    Thompson, Rachel E.
    Rossi, Sabrina H.
    Stewart, Grant D.
    Walter, Fiona M.
    Griffin, Simon
    Zhou, Yin
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2022, 72 (714): : E11 - E18
  • [33] Lung cancer risk prediction models based on pulmonary nodules: A systematic review
    Wu, Zheng
    Wang, Fei
    Cao, Wei
    Qin, Chao
    Dong, Xuesi
    Yang, Zhuoyu
    Zheng, Yadi
    Luo, Zilin
    Zhao, Liang
    Yu, Yiwen
    Xu, Yongjie
    Li, Jiang
    Tang, Wei
    Shen, Sipeng
    Wu, Ning
    Tan, Fengwei
    Li, Ni
    He, Jie
    [J]. THORACIC CANCER, 2022, 13 (05) : 664 - 677
  • [34] A systematic review and quality assessment of individualised breast cancer risk prediction models
    Louro, Javier
    Posso, Margarita
    Boon, Michele Hilton
    Roman, Marta
    Domingo, Laia
    Castells, Xavier
    Sala, Maria
    [J]. BRITISH JOURNAL OF CANCER, 2019, 121 (01) : 76 - 85
  • [35] Can We Personalize Colorectal Cancer Screening? A Systematic Review of Models to Predict Risk of Colorectal Neoplasia
    Ma, Gene K.
    Ladabaum, Uri
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S215 - S215
  • [36] Prediction models for the risk of developing nephropathy in people with type 2 diabetes. A systematic review
    van der Heijden, A. A.
    Gort, M.
    Elders, P. J. M.
    Nijpels, G.
    Beulens, J. W. J.
    [J]. DIABETOLOGIA, 2018, 61 : S493 - S493
  • [37] Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
    Wei Xu
    Yazhou He
    Yuming Wang
    Xue Li
    Jane Young
    John P. A. Ioannidis
    Malcolm G. Dunlop
    Evropi Theodoratou
    [J]. BMC Medicine, 18
  • [38] Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
    Xu, Wei
    He, Yazhou
    Wang, Yuming
    Li, Xue
    Young, Jane
    Ioannidis, John P. A.
    Dunlop, Malcolm G.
    Theodoratou, Evropi
    [J]. BMC MEDICINE, 2020, 18 (01) : 172
  • [39] Risk Prediction Models for Hospital Readmission A Systematic Review
    Kansagara, Devan
    Englander, Honora
    Salanitro, Amanda
    Kagen, David
    Theobald, Cecelia
    Freeman, Michele
    Kripalani, Sunil
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (15): : 1688 - 1698
  • [40] Prediction models for the risk of gestational diabetes: a systematic review
    Marije Lamain – de Ruiter
    Anneke Kwee
    Christiana A. Naaktgeboren
    Arie Franx
    Karel G. M. Moons
    Maria P. H. Koster
    [J]. Diagnostic and Prognostic Research, 1 (1)